Shin, W., Choi, J., Yun, H., Han, O., Cho, H., Hompesch, M., & Baek, S. (2022). PSUN305 A Double-Blind, Placebo-Controlled Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HM15136 in Obese or Overweight Subjects with Co-morbidities. Journal of the Endocrine Society, 6(Supplement_1), A409. https://doi.org/10.1210/jendso/bvac150.851
Chicago Style (17th ed.) CitationShin, Wonjung, JaeDuk Choi, Hyori Yun, OakPil Han, Hyungjin Cho, Marcus Hompesch, and Seungjae Baek. "PSUN305 A Double-Blind, Placebo-Controlled Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HM15136 in Obese or Overweight Subjects with Co-morbidities." Journal of the Endocrine Society 6, no. Supplement_1 (2022): A409. https://doi.org/10.1210/jendso/bvac150.851.
MLA (9th ed.) CitationShin, Wonjung, et al. "PSUN305 A Double-Blind, Placebo-Controlled Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HM15136 in Obese or Overweight Subjects with Co-morbidities." Journal of the Endocrine Society, vol. 6, no. Supplement_1, 2022, p. A409, https://doi.org/10.1210/jendso/bvac150.851.